Clinical features, survival experience, and profile of plakophylin-2 gene mutations in participants of the Arrhythmogenic Right Ventricular Cardiomyopathy Registry of South Africa

Heart Rhythm

Volumn 6, Issue 11 SUPPL., 2009, Pages

  Watkins, David A ^a   Hendricks, Neil ^a   Shaboodien, Gasnat ^a   Mbele, Mzwandile ^a   Parker, Michelle ^a   Vezi, Brian Z ^a   Latib, Azeem ^a   Chin, Ashley ^a   Little, Francesca ^b   Badri, Motasim ^a   Moolman Smook, Johanna C ^a,c   Okreglicki, Andrzej ^a   Mayosi, Bongani M ^a  

^a UNIVERSITY OF CAPE TOWN   (South Africa)

^b UNIVERSITY OF CAPE TOWN   (South Africa)

^c STELLENBOSCH UNIVERSITY   (South Africa)

Author keywords

Arrhythmogenic right ventricular cardiomyopathy; Registry; South Africa; Survival

Indexed keywords

PLAKOPHILIN;

ADULT; ARTICLE; CLINICAL TRIAL; ETHNOLOGY; FEMALE; FOUNDER EFFECT; GENETIC POLYMORPHISM; GENETICS; GENOTYPE; HAPLOTYPE; HEART RIGHT VENTRICLE DYSPLASIA; HUMAN; MALE; MORTALITY; MULTICENTER STUDY; MUTATION; ONSET AGE; RACE; REGISTER; SOUTH AFRICA; SURVIVAL; SURVIVAL RATE;

ADULT; AGE OF ONSET; ARRHYTHMOGENIC RIGHT VENTRICULAR DYSPLASIA; CONTINENTAL POPULATION GROUPS; FEMALE; FOUNDER EFFECT; GENOTYPE; HAPLOTYPES; HUMANS; MALE; MUTATION; PLAKOPHILINS; POLYMORPHISM, GENETIC; REGISTRIES; SOUTH AFRICA; SURVIVAL ANALYSIS; SURVIVAL RATE;

EID: 75549084678     PISSN: 15475271     EISSN: 15563871     Source Type: Journal    
DOI: 10.1016/j.hrthm.2009.08.018     Document Type: Conference Paper

References (34)

1. Herren T, Gerber PA, Duru F. Arrhythmogenic right ventricular cardiomyopathy/ dysplasia: a not so rare "disease of the desmosome" with multiple clinical presentations. Clin Res Cardiol 2009;98:141-158.
2. Gerull B, Heuser A, Wichter T, et al. Mutations in the desmosomal protein plakophilin-2 are common in arrhythmogenic right ventricular cardiomyopathy. Nat Genet 2004;36:1162-1164.
3. Hulot J-S, Jouven X, Empana J-P, et al. Natural history and risk stratification of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation 2004; 110:1879-1884.
4. McKenna WJ, Thiene G, Nava A, et al. Diagnosis of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Task Force of the Working Group Myocardial and Pericardial Disease of the European Society of Cardiology and of the Scientific Council on Cardiomyopathies of the International Society and Federation of Cardiology. Br Heart J 1994;71:215-218.
5. Munclinger MJ, Patel JJ, Mitha AS. Follow-up of patients with arrhythmogenic right ventricular cardiomyopathy dysplasia. S Afr Med J 2000;90:61-68.
6. Matolweni L, Bardien S, Rebello G, et al. Arrhythmogenic right ventricular cardiomyopathy type 6 (ARVC6): support for the locus assignment, narrowing of the critical region and mutation screening of three candidate genes. BMC Med Genet 2006;7:29.
7. Sliwa K, Damasceno A, Mayosi BM. Epidemiology and etiology of cardiomyopathy in Africa. Circulation 2005;112:3577-3583.
8. Corrado D, Fontaine G, Marcus FI, et al. Arrhythmogenic right ventricular dysplasia/cardiomyopathy: need for an international registry. Circulation 2000; 101:101e-106e.
9. van Tintelen JP, Entius MM, Bhuiyan ZA, et al. Plakophilin-2 mutations are the major determinant of familial arrhythmogenic right ventricular dysplasia/cardiomyopathy. Circulation 2006;113:1650-1658.
10. Lahtinen AM, Lehtonen A, Kaartinen M, et al. Plakophilin-2 missense mutations in arrhythmogenic right ventricular cardiomyopathy. Int J Cardiol 2008;126:92-100.
11. Syrris P, Ward D, Asimaki A, et al. Clinical expression of plakophilin-2 mutations in familial arrhythmogenic right ventricular cardiomyopathy. Circulation 2006;113:356-364.
12. Dalal D, Molin LH, Piccini J, et al. Clinical features of arrhythmogenic right ventricular dysplasia/cardiomyopathy associated with mutations in plakophilin-2. Circulation 2006;113:1641-1649.
13. Latib MA, Michaels K, Mayosi BM. Initial report of the Arrhythmogenic Right Ventricular Cardiomyopathy Registry of South Africa: 2004. Cardiovasc J S Afr 2004;15:237-238.
14. Hamid MS, Norman M, Quraishi A, et al. Prospective evaluation of relatives for familial arrhythmogenic right ventricular cardiomyopathy/dysplasia reveals a need to broaden diagnostic criteria. J Am Coll Cardiol 2002;40:1445-1450.
15. Moolman-Smook JC, De Lange WJ, Bruwer EC, et al. The origins of hypertrophic cardiomyopathy-causing mutations in two South African subpopulations: a unique profile of both independent and founder events. Am J Hum Genet 1999;65:1308-1320.
16. Dalal D, Nasir K, Bomma C, et al. Arrhythmogenic right ventricular dysplasia: a United States experience. Circulation 2005;112:3823-3832.
17. Marcus FI, Fontaine GH, Guiraudon G, et al. Right ventricular dysplasia: a report of 24 adult cases. Circulation 1982;65:384-398.
18. Corrado D, Basso C, Thiene G, et al. Spectrum of clinicopathologic manifestations of arrhythmogenic right ventricular cardiomyopathy/dysplasia: a multicenter study. J Am Coll Cardiol 1997;30:1512-1520.
19. Nava A, Bauce B, Basso C, et al. Clinical profile and long-term follow-up of 37 families with arrhythmogenic right ventricular cardiomyopathy. J Am Coll Cardiol 2000;36:2226-2233.
20. Brink PA, Crotti L, Corfield V, et al. Phenotypic variability and unusual clinical severity of congenital long-QT syndrome in a founder population. Circulation 2005;112:2602-2610.
21. Goldman A, Krause A, Ramsay M, et al. Founder effect and prevalence of myotonic dystrophy in South Africans: molecular studies. Am J Hum Genet 1996;59:445-452.
22. Groenewald JZ, Liebenberg L, Groenewald IM, et al. Linkage disequilibrium analysis in a recently founded population: evaluation of the variegate porphyria founder in South African Afrikaners. Am J Hum Genet 1998;62:1254-1258.
23. Kotze MJ, De Villiers WJ, Steyn K, et al. Phenotypic variation among familial hypercholesterolemics heterozygous for either one of two Afrikaner founder LDL receptor mutations. Arterioscler Thromb Vasc Biol 1993;13:1460-1468.
24. Le Saux O, Beck K, Sachsinger C, et al. Evidence for a founder effect for pseudoxanthoma elasticum in the Afrikaner population of South Africa. Hum Genet 2002;111:331-338.
25. Tipping AJ, Pearson T, Morgan NV, et al. Molecular and genealogical evidence for a founder effect in Fanconi anemia families of the Afrikaner population of South Africa. Proc Natl Acad Sci U S A 2001;98:5734-5739.
26. Mayosi BM, Millar RS. The 1995 survey of cardiac pacing in South Africa. S Afr Med J 1988;88(Cardiovasc Suppl 4):C207-C11.
27. Benatar SR. Medicine and healthcare in south Africa. N Engl J Med 1991;325: 30-36.
28. Heidbuchel H, Hoogsteen J, Fagard R, et al. High prevalence of right ventricular involvement in endurance athletes with ventricular arrhythmias: role of an electrophysiologic study in risk stratification. Eur Heart J 2003; 24:1473-1480.
29. Kirchhof P, Fabritz L, Zwiener M, et al. Age- and training-dependent development of arrhythmogenic right ventricular cardiomyopathy in heterozygous plakoglobin-deficient mice. Circulation 2006;114:1799-1806.
30. Awad MM, Calkins H, Judge DP. Mechanisms of disease: molecular genetics of arrhythmogenic right ventricular dysplasia/cardiomyopathy. Nat Clin Pract Cardiovasc Med 2008;5:258-267.
31. Corrado D, Pelliccia A, Bjornstad HH, et al. Cardiovascular pre-participation screening of young competitive athletes for prevention of sudden death: proposal for a common European protocol: Consensus Statement of the Study Group of Sport Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005;26:516-524.
32. Mayosi BM, Flisher AJ, Lalloo UG, et al. The burden of noncommunicable diseases in South Africa. The Lancet 2009;374:934-947.
33. Bradshaw D, Nannan N. Health status. S Afr Health Rev 2003/2004:45-56.
34. Awad M, Dalal D, Tichnell C, et al. Recessive arrhythmogenic right ventricular dysplasia due to novel cryptic splice mutation in PKP2. Hum Mutat 2006;27: 1157.